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Abstract
We present two complementary model-based methods for calculating the risk of international
spread of the novel coronavirus SARS-CoV-2 from the outbreak epicentre. One model aims to
calculate the number of cases that would be exported from an endemic country to disease-free
regions by travellers. The second model calculates the probability that an infected traveller will
generate at least one secondary autochthonous case in the visited country. Although this paper
focuses on the data from China, our methods can be adapted to calculate the risk of import-
ation and subsequent outbreaks. We found an average R0 = 5.31 (ranging from 4.08 to 7.91)
and a risk of spreading of 0.75 latent individuals per 1000 travellers. In addition, one infective
traveller would be able to generate at least one secondary autochthonous case in the visited
country with a probability of 23%.
Introduction
Given the extent of global travel patterns [1–3], newly emerging diseases can rapidly spread glo-
bally. In general, respiratory pathogens spread faster [4] than vector-borne viruses [5, 6] or those
that require very close contact such as Ebola [7] or Lassa [8]. In late 2019, a novel coronavirus,
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
which rapidly spread globally [9] and caused epicentres of COVID-19 disease in multiple coun-
tries. SARS-CoV-2 has a high reproduction rate and is easily transmitted via respiratory droplets
among humans [10]. Population flow data between Wuhan and other major cities in mainland
China were clearly correlated with the number of cases exported from Wuhan to other city clus-
ters in mainland China before the lock-down [11]. The potential for rapid international spread
via air travel was enormous, and indeed first exportations followed high travel volumes to
Thailand, Hong Kong and Singapore [9]. As of 1 June 2020, more than 6 million cases and
more than 360 000 deaths due to COVID-19 have been reported in more than 200 countries.
The speed of spread depends on the air passenger volumes, the basic reproduction rate as a
measure of transmissibility and the incubation time [12, 13]. In this paper we present two
complementary methods for calculating the risk of international spread of a new virus from
an epicentre. The first method aims to calculate the number of cases that would be exported
from an endemic country to disease-free regions by travellers. The second method calculates
the probability that one of the infected travellers will generate at least one secondary autoch-
thonous case in the visited country. The calculation for disease exportation is simpler than the
calculation for infection importation. One difference is that in the case of disease importation
travellers to endemic areas return infective to their home country, whereas in the case of dis-
ease exportation travellers depart from their endemic home country in a latent state. This latter
assumption is based on the conjecture that symptomatic individuals do not travel. For asymp-
tomatic travellers, their disease will manifest itself either during the flight or after arrival in the
visited disease-free country dependent on the time of infection and incubation time.
In the case of disease importation, the key parameter is the force of infection of the disease
in the visited endemic country. In the case of disease exportation, the key parameter is the
latency duration of the disease in the travellers’ home country. In the case of disease import-
ation latency is not too important and the model considers only susceptible, infected and
removed individuals. On the other hand, in the case of disease
exportation latency is important because it is assumed that
infected and symptomatic individuals are either so sick that
they do not manage to travel or are not allowed to board the
plane due to exit screening.
Methods
The models
Model 1. Calculating the number of exported cases from an
endemic country
In this section we consider the case of infective travellers from an
endemic country visiting a disease-free country, and so exporting
the infection to the visited country. Once arriving in the visited
disease-free country those infective visitors may trigger an out-
break that can establish itself depending on the value of the
basic reproduction number R0 of the infection in the disease-free
country. If R0 is greater than one, the disease will spread. We will
approach the problem with a deterministic formulation.
The model is a classic susceptible-exposed-infected-removed
(SEIR) model given by the following set of equations:
dSH(t)
dt
=− bSH IHNH − mHSH + LH
dEH(t)
dt
=bSH IHNH − (mH + dH)EH
dIH(t)
dt
= dHEH − (mH + aH + gH)IH
dRH(t)
dt
= gHIH − mHRH(t),
(1)
where SH(t) is the number of susceptible individuals, EH(t) is the
number of incubating and asymptomatic individuals, who have
the disease but do not transmit it, IH(t) is the number of infec-
tious individuals, RH(t) is the number of individuals recovered
from infection and NH(t) = SH(t) + EH(t) + IH(t) + RH(t) is the
total population. The parameters are β, the potentially infective
contact rate, δH, the inverse of the incubation (or latency) period,
γH, the duration of infectiousness and μH and αH are the natural
and disease-induced mortality rates, respectively.
Hence, the number of new infections per unit of time corre-
sponds to the infection incidence, denotedλ(t) = βSH(IH(t)/NH(t)).
The basic reproduction number, R0, that is, the number of sec-
ondary infection produced by an infectious individual in an
entirely susceptible population along his/her infectiousness per-
iod, associated with system (1) is deduced in Appendix A:
R0 = dHb(dH + mH)(gH + aH + mH)
(2)
For exportations, our interest is the prevalence of latent infec-
tions in the local population, from which, some individuals will
travel already infected but not yet symptomatic. We estimated
the disease prevalence in the population, that is, the number of
infected individuals at each instant of time, IH(t), by integrating









Dividing IH(t) by the size of the local population, NH, we
obtain the prevalence, that is, the proportion of infectious indivi-
duals, pI(t), in the endemic country as follows:










On the other hand, multiplying the number of visitors to a
given disease-free country by the prevalence of latent (infected
but not infectious individuals), pE(t), generates the number of
infected visitors or exportations of infections. Integrating the
second equation of (1) yields the following quantity EH(t),









Dividing EH(t) the total population NH, yields the prevalence
of infected but not yet infectious individuals in the home country
as follows:












To obtain this prevalence, the force of infection of the disease,
that is, the number of new cases of infection per time unit, β
(IH(t)/NH), in this endemic region is a necessary input variable.
The best information normally available is the notification rate
of infectious individuals, δHEH (this term is the number of indi-
viduals that evolve from the latent to the infectious state), pro-
vided by disease surveillance systems. Equation (6) will be used
later in the paper.
Model 2. Calculating the probability of infection introduction in a
disease-free country
In this section we calculate the probability that an infected travel-
ler (index case) from an endemic country arriving infective in a
disease-free country generates a secondary autochthonous case.
On arriving in the disease-free country each infected visitor
will trigger an outbreak that will establish itself depending if the
value of the basic reproduction number R0 of the infection is
greater than one. Since we are dealing with a low number of tra-
vellers, we need to approach the problem with a stochastic
formulation.
This model assumes that a density of one infected individual,
IH(t0), arrives at t = t0 and remains infective for a period of (μH +
γH + αH)
−1 days, that is
IH(t) = IH(t0) exp [−(mH + gH + aH)(t − t0)], t ≥ t0 (7)
where μH, γH and αH are the natural mortality rate, the recovery
rate from infection and the disease-induced mortality rate,
respectively. If the region where these infected travellers arrive
had an area A the number of them is IH(t0)A.
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The total number of new cases infected by these travellers, Δ








where β is the potentially infective contact per unit time between
infected and one susceptible individuals, and SH and NH are the
susceptible and total population, respectively.
The risk of New Cases invasion of a previously unaffected
country, Risknew cases, can be defined as the probability that at
least one autochthonous case be produced by the arrival of one
single infected individual at the area during his/her infectiousness
period. For calculating this risk, we assumed a non-homogeneous
simple birth process [5], which describes the propagation of the
disease.
Let Pn(t) be the probability of n cases. The probability gener-
ating function of such process is P(x, t) = ∑n Pnxn. After some
calculation, we obtain the probability of x cases at time t [5, 6]:
P(x, t) = 1+ 1
(er(t)/(x − 1))− t0 l(t)er(t)dt
{ }a
(9)
where a = IH(t0)A, λ(t) = β((IH(t0)SH(t))/NH) and
r(t) = t0 −l(t)u(t− t0)dt.
We have assumed that the region to be studied has an area A,
the number of infected travellers that arrived at t = t0 is a = IH(t0)
A. We set a = 1 from now on, that is, a single index case arrives at
the non-affected area.
Expanding (9) in powers of x we find that the risk, that is, the
probability of having n infected individuals at time t, denoted
Risknew cases(n, t) as












The risk (probability) of having no infected individuals is
Risknew cases(0, t) = pa (9b)
In equations (9a) and (9b) p = 1− (1/(er(t) + t0 l(t)u(t− t0)
er(t)dt)) and s = 1− (er(t)/(er(t) + t0 l(t)u(t− t0)er(t)dt)).
The probability of at least one autochthonous case in a previ-
ously unaffected region can be calculated as the tail probability,
that is, the probability of the infection invading the previously
non-affected area:




for m= 1, equation (5) reduces to
P(Number of cases . 1) = Risknew cases = (1− p)s (11)
Results. Illustrating the models
To illustrate the models’ performance, we consider the case of the
outbreak of COVID-19 in the province of Hubei, China. At the
time of writing, this province was responsible for approximately
82% of the total number of COVID-19 cases in the world.
We used data from the WHO website [7]. As we use the case of
Hubei outbreak only to illustrate the models, we calculated the
incidence of cases in that province by multiplying the total
world number of daily cases of infections by 0.84. As China modi-
fied the diagnostic criteria along the course of the outbreak, we
used incidence data only until 11 February 2020.
Illustrating model 1
We begin by fitting a continuous function to the daily number of
reported cases, that is, the incidence of new cases per time unit,
δHEH(t). We assume here that new cases are symptomatic cases.
This assumption is probably very reasonable for the Hubei epi-
demic because tests were developed only at the end of the
Hubei outbreak. The function has the bell-shaped form:





where ci, (i = 1, …, 3) are the fitting parameters and t is the time.
The fitting of reported new cases per time unit to equation
(11) is shown in Figure 1.
Note that equation (12) fits the Hubei COVID-19 cases rea-
sonably well. If equation (12) is inserted into equation (4), the
COVID-19 prevalence at each instant of time IH(t) is obtained.
On the other hand, we can fit the initial exponential phase (eϕt)
of the prevalence curve obtained in Figure 1. It is then possible to
estimate the value of R0 according to (see Appendices A and B):
R0 = w
2 + w[(mH + aH + gH)+ (mH + dH)]
(mH + aH + gH)(mH + dH)
+ 1 (13)
where w is the rate of the exponential growth and mH, aH, gH and
δH as in equation (1). The parameter values used to calculate R0
are shown in Table 1.
The value of the estimated R0 resulted in an average of 5.31
(ranging from 4.08 to 7.91) for the outbreak in the province of
Hubei. Figure 2 shows the fitting of data from Hubei province
to an exponential function.
It is possible, in principle, to fit the parameters of system (1) in
order to retrieve the prevalence curve. The parameters then can be
used to estimate the number and the prevalence of latent indivi-
duals (equations (5) and (6)). Alternatively, taken the COVID-19
average latency period of 3 days (i.e. δH = (1/3) per day), EH(t) can
be calculated by simply dividing equation (11) by δH, that is,




from which it is possible to estimate the prevalence of asymptom-
atic latents in the population:
pE(t) = EH(t)NH (15)
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The result for the case of COVID-19 in the province of Hubei
is shown in Figure 3.
As an example in a cohort of travellers that depart from Hubei
at week 15 the relative number of latent individuals carrying the
COVID-19 virus is of 0.75 individuals per 1000 travellers, which
is much higher than Ebola, for instance [7]. In other words, out
of 1333 travellers from that region, 1 would be infected.
Illustrating model 2
Next, we assume that one individual traveller from an endemic
country (index case) visits a disease-free country and remains
infective for a period of (μH + γH + αH)
−1 days.
To calculate the probability of a secondary autochthonous case
generated by each infected traveller, we used the incidence curve
described above to calculate the probability generating function
according to equation (9) where the incidence is represented by
the parameter λ(t).
Next, we calculate the values of parameters π and σ from equa-
tions (9a) and (9b) to estimate the probability that the infected
traveller who imported the virus to his/her home country
would generate at least one secondary case, according to equation
(11). The result is 23%, that is, one single infective traveller would
be able to generate at least one secondary case along his/her infec-
tiousness period, with probability of 23%. Note that the expected
number of secondary case is the average value of the basic repro-
ductive rate, that is, 5.31.
Discussion
In this paper we propose two complementary models for calculat-
ing the risk of international spreading of the novel coronavirus
SARS-CoV-2 from the initial epicentre of COVID-19 in
Wuhan, China. One model addresses the case of disease export-
ation from the epidemic outbreak and considers a certain number
of travellers leaving the epidemic region during the incubation
period, thereby importing the virus into another country. The
model is deterministic and was illustrated with the data from
the initial outbreak in the province of Hubei in China.
The first model’s simulation resulted in an average R0 = 5.31
(ranging from 4.08 to 7.91) and a risk of spreading of 0.75 latent
individuals per 1000 travellers. If we consider the monthly num-
ber of travellers from the city of Wuhan described by Wu et al.
[14] to other Asian countries of around 86 000, we should expect
almost 65 cases of the infection to these countries.
The second model addresses the case of the probability of dis-
ease introduction in a disease-free country by an index case from
the epidemic epicentre. The model considers the situation in
which a single infected traveller from an epidemic region, acquires
the infection and travels to a disease-free country where he/she
can trigger a local outbreak. As we consider a single traveller we
approach the case with a stochastic formulation. We simulated
the model with the same case of the province of Hubei in China
and the results show that one single infective traveller would be
able to generate at least one secondary autochthonous case in the
visited country, along his/her infectiousness period, with a prob-
ability of 23%. This probability should be contrasted with the aver-
age number of secondary cases the traveller would generate at his/
her home country of 5.31. The latter is the average basic reproduc-
tion number of COVID-19 in the community of Hubei and should
not be essentially different elsewhere when the population is
Fig. 1. Fitting of reported cases to equation (11).
Table 1. Parameter’s values to calculate R0 as in equation (13)
Parameter Value Comments
ϕ 0.232 Fitted to the Hubei data (see
Fig. 2)
μH 3.91 × 10
−5 per day Life expectancy of 70 years
αH 7.73 × 10
−4 per day Lethality of 3.2%
γH 0.2 per day Duration of symptoms of 5 days
δH 0.167–1.0 per day Latency ranging from 1 to 6 days
Fig. 2. Fitting the new cases per capita to an exponential function, the data from
Hubei province.
Fig. 3. Expected number of latent travellers.
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immunologically naïve and there is a homogenously mixing pat-
tern of contact. In a stochastic context, even when R0 is greater
than 1, there is a probability of extinction of the infection.
Moreover, the 23% risk of exportation means the probability that
one traveller when arriving in the infectious condition would gen-
erate at least one secondary autochthonous case of COVID-19.
Some important limitations are worthwhile mentioning about
our approach:
Our model assumes that only latent individuals travel. However, it is possible
that some mildly symptomatic cases can escape from the screening measures
at the moment of the travel. Moreover, for example, a number of the earliest
known exported cases travelled when sick. There are reports of travellers tak-
ing antipyretics to mask their fever, and then board the plane. However, the
number of patients who travel with mild symptoms is likely to be very small
when compared to the non-symptomatic latent individuals and this should
not interfere with our results. Furthermore, our results will depend on the
incidence of COVID-19 in the departing country. For example, during
the peak of the COVID-19 outbreak in Europe, about 3−6% of air passen-
gers were SARS-CoV-2 positive on repatriation flights [15].
From the modelling perspective an important limitation is the
homogeneously mixing assumption. We are well aware of the
many heterogeneities involved in transmission of a directly trans-
mitted pathogen like SARS-CoV-2. In addition, the deterministic
approach of the exportation model is an approximation of the
real dynamics involved in transmission. However, both limitations
above do not invalidate the qualitative results of the models.
Considering the large number of people involved in the current
epidemic the deterministic approach and the homogeneously mix-
ing assumption can be considered as a good first approximation of
the problem. However, heterogeneities can be introduced in the
model using the techniques described in [16], and these heteroge-
neities could have significant influences in the quantitative results
of our model. For instance, if variation in infectiousness would
be included, the risk of spread could be lower on average, and
the speed of the infection spread could be affected as well.
Equation (1) assumes that only infected individuals, IH, are
infectious. In fact, at least a fraction f of the exposed individuals,
EH, may be infectious. So IH in the first and the second equations
of system (1) should be replaced with IH + fEH. Equation (A6) in
Appendix A shows that eH(0) and iH(0) are related. This artificial
feature can be removed by adding to equations (A1) and (A2) the
initial infection terms eH(0)e−(mH+dH)t and iH(0)e−(mH+aH+gH)t ,
respectively, and solving them [10].
Another limitation of our approach concerns the data upon
which we exemplify our application. We have access only to the
global number of cases from the WHO website on COVID-19
and in order to apply the model for the province of Hubei we
assumed that that region represents 84% of the global cases.
Hence, we assumed a direct proportionality of the cases to simu-
late the model on these data. In addition, we simulate the model
until 11 February because China modified the diagnostic criteria
along the course of the outbreak. The incidence curve, however,
had already started to wane at that time. Moreover, we used the
incidence data for the province of Hubei only to exemplify the
models, which could be applied, in principle, to other situations
related to the spread of pathogens from outbreak epicentres.
Finally, it should be commented that the model assumes that
the potentially infective contact rate β in the receptive country
of the index cases is the same as in the province of Hubei. In
fact, β has a remarkable seasonality, being higher during winter
time, declining throughout spring time into summer time.
Therefore, the probability of autochthonous cases is super-
estimated for receptive countries during the summer season.
We believe that the models presented here may present a sig-
nificant step forward in estimating the risk of importation of the
novel coronavirus SARS-CoV-2.
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Appendix A
Finding the basic reproduction number given by equation (2)
Linearising the second and the third equations of the system (1) around
the no-disease state, that is, SH =NH− SH, EH = 0 + eH, IH = 0 + iH and RH =
0 + rH when SH, eH, iH and rH are small, we obtain
deH(t)
dt
= biH − (mH + dH)eH (A1)
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diH(t)
dt
= dHeH − (mH + aH + gH)iH (A2)
Assuming
eH(t) = c1elt (A3)
iH(t) = c2elt (A4)
we get
− (mH + dH + l)c1 + bc2 = 0 (A5)
dHc1 − (mH + aH + gH + l)c2 = 0 (A6)
The above system has non-trivial solution if the determinant of the
unknown c1 and c2 are different from zero. We then obtain
(mH + dH + l)(mH + aH + gH + l)− bdH = 0 (A7)
Equation (A5) has a positive solution when
R0 = bdH(mH + dH)(mH + aH + gH)
(A8)
is greater than 1. Thus, R0 is the basic reproduction number.
Also,
R0 = l
2 + l[(mH + dH)+ (mH + aH + gH)]
(mH + dH)(mH + aH + gH)
+ 1. (A9)
Appendix B
Now we relate the basic reproduction number (equation (A5)) to the rate w of
new cases Nc(t) given by equation
Nc(t) = Nc(0)ewt . (B1)
The rate w is obtained by fitting equation (B1) to the initial exponential
growth shown in Figure 2.
Using equation (A4) we have that the number of new infected cases at t = 0
is given by
Nc(0) = dHeH(0). (B2)
Since eH(t) and iH(t) are given by equations (A3) and (A4) and λ is the
positive root of equation (A7), we have
eH(0) = c1 (B3)
and
iH(0) = c2. (B4)
But
dHeH(0)− (mH + aH + gH + l)iH(0) = 0 (B5)
from equation (A2). So,
eH(0) = (mH + aH + gH + l)
dH
iH(0). (B6)
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